Ezh2, a novel target in detection and therapy of breast cancer
- PMID: 28579806
- PMCID: PMC5449122
- DOI: 10.2147/OTT.S138777
Ezh2, a novel target in detection and therapy of breast cancer
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
-
- DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics. 2013. CA Cancer J Clin. 2014;64(1):52–62. - PubMed
-
- Martins D, Beca F, Schmitt F. Metastatic breast cancer: mechanisms and opportunities for cytology. Cytopathology. 2014;25(4):225–230. - PubMed
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics. 2013. CA Cancer J Clin. 2013;63(1):11–30. - PubMed
-
- Beaumont T, Leadbeater M. Treatment and care of patients with metastatic breast cancer. Nurs Stand. 2011;25(40):49–56. - PubMed
-
- Wang X, Hu B, Shen H, et al. Clinical and prognostic relevance of EZH2 in breast cancer: a meta-analysis. Biomed Pharmacother. 2015;75:218–225. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources